🌬️ Obstructive Lung Disease
The Poiseuille relationship and how obstructive spirometry patterns are recognized are covered with Volumes, Compliance & PFTs — the physiologic basis for everything below.
Asthma
- Clinical: episodic wheeze, cough (may be the only symptom, "cough-variant asthma"), chest tightness, dyspnea, often nocturnal or exercise-triggered.
- Key histologic findings: mucus plugs containing whorled epithelial casts (Curschmann spirals), and crystalline eosinophil-derived debris (Charcot-Leyden crystals) in sputum.
- Hallmark: reversible airflow obstruction — FEV1 improves substantially after bronchodilator administration, distinguishing it from COPD.
- Status asthmaticus: a severe attack unresponsive to standard bronchodilator therapy — a medical emergency.
- Recognized clinical subtypes include extrinsic (allergen-driven, typically childhood-onset), intrinsic (non-allergic, typically adult-onset), exercise-induced, and cold air–induced asthma — different triggers converging on the same final bronchoconstrictive pathway.
Chronic Bronchitis
- Clinical definition: productive cough for ≥3 months in ≥2 consecutive years.
- Driven by chronic irritant exposure (overwhelmingly cigarette smoke) → goblet cell hyperplasia and submucosal gland enlargement → mucus overproduction and plugging.
- Quantified histologically by the Reid index — the ratio of submucosal gland thickness to the thickness of the airway wall between the epithelium and the cartilage; an elevated ratio (roughly >0.5) supports the diagnosis.
- "Blue bloater" phenotype: chronic hypoxemia/hypercapnia → cyanosis; cor pulmonale → peripheral edema.
Emphysema
- Destruction of alveolar septa distal to the terminal bronchiole → permanent airspace enlargement and loss of elastic recoil.
- "Pink puffer" phenotype: near-normal oxygenation maintained by increased ventilatory effort (pursed-lip breathing), so cyanosis is late; barrel chest from air trapping.
- Centriacinar (proximal acinus, upper lobes): overwhelmingly smoking-related.
- Panacinar (entire acinus, lower lobes): classic for α1-antitrypsin deficiency.
- Paraseptal (distal acinus, adjacent to pleura/scarred tissue): can rupture and cause spontaneous pneumothorax, notably in younger patients.
Chronic bronchitis and emphysema are two ends of the same smoking-driven spectrum — gland/goblet hypertrophy causing mucus obstruction versus protease-mediated destruction of elastic recoil — which is why real COPD patients usually show overlapping features rather than a pure phenotype.
α1-Antitrypsin Deficiency Mechanism
α1-antitrypsin deficiency also causes liver disease (cirrhosis) via accumulation of misfolded protein in hepatocytes — a classic "gain of toxic function" mechanism distinct from the lung disease (a "loss of protective function" mechanism).
Bronchiectasis
- Permanent, irreversible dilation of the bronchi caused by a cycle of chronic infection and inflammation that destroys the bronchial wall.
- Presents with copious purulent sputum, recurrent infections, hemoptysis, digital clubbing.
- Common associations: cystic fibrosis, primary ciliary dyskinesia, chronic bronchial obstruction (tumor, foreign body), recurrent aspiration.
Consolidated lung transmits sound better — expect increased tactile fremitus, dullness to percussion, and bronchial breath sounds over a lobar bacterial pneumonia. This is the opposite pattern from pneumothorax or atypical/viral pneumonia.
💊 Asthma & COPD Pharmacology
| Drug Class | Mechanism | Notable Agents | Key Adverse Effects |
|---|---|---|---|
| Short-acting β₂-agonist (SABA) | β₂ receptor → ↑ cAMP → smooth muscle relaxation | Albuterol | Tremor, tachycardia, hypokalemia, hyperglycemia, hypomagnesemia |
| Long-acting β₂-agonist (LABA) | Same as SABA, longer duration; not for acute attacks | Salmeterol, formoterol | Same as SABA; always co-administer with inhaled corticosteroid |
| Muscarinic antagonist | Blocks M3 receptors → prevents vagally-mediated bronchoconstriction | Ipratropium (short), tiotropium (long) | Dry mouth, urinary retention |
| Inhaled corticosteroid | Suppresses airway inflammatory cascade (transcriptional) | Fluticasone, budesonide | Oral thrush, dysphonia; minimal systemic effect vs. oral steroids |
| Leukotriene receptor antagonist | Blocks CysLT1 receptor → prevents leukotriene-driven bronchoconstriction/inflammation | Montelukast, zafirlukast | Useful in aspirin-exacerbated respiratory disease |
| 5-lipoxygenase inhibitor | Blocks leukotriene synthesis upstream | Zileuton | Hepatotoxicity |
| Mast cell stabilizer | Prevents mast cell degranulation | Cromolyn, nedocromil | Prophylactic only, not for acute attacks; nedocromil's most notable side effect is an unpleasant taste |
| Methylxanthine | Phosphodiesterase inhibition → ↑ cAMP; narrow therapeutic index | Theophylline | Seizures, arrhythmias; metabolized by CYP450 (many interactions) |
| Anti-IgE monoclonal antibody | Binds free IgE, prevents mast cell sensitization | Omalizumab | Reserved for severe allergic asthma |
| Anti-IL-5 / IL-5 receptor biologics | Block IL-5 signaling → ↓ eosinophil differentiation, activation, and survival | Mepolizumab, reslizumab (target IL-5); benralizumab (targets the IL-5 receptor) | Maintenance therapy for severe eosinophilic asthma |
| Anti-IL-4 receptor biologic | Blocks the shared receptor for IL-4 and IL-13 signaling | Dupilumab | Also used in other type 2/allergic conditions (e.g., atopic dermatitis) |
| PDE-4 inhibitor | Inhibits phosphodiesterase-4 → ↑ cAMP → ↓ airway inflammation | Roflumilast | Used specifically in COPD to reduce exacerbation frequency, not for acute bronchospasm |
β2-agonists relieve bronchospasm but do nothing to treat the underlying inflammation of asthma — that's the job of inhaled corticosteroids, which is why persistent asthma requires a controller medication, not bronchodilators alone.
Systemic Corticosteroid Adverse Effects
Reserved for moderate-to-severe exacerbations because, unlike the inhaled route, systemic (oral/IV) corticosteroids carry a broader adverse effect profile: osteoporosis, Cushingoid features, psychiatric symptoms (including psychosis), impaired glucose tolerance, increased infection risk, hypertension, cataracts, and acne.
Regimens for Acute Exacerbations
Acute asthma exacerbation
- Short-acting β2-agonist + ipratropium (nebulized), systemic corticosteroids, and supplemental magnesium sulfate in more severe cases.
- Leukotriene receptor antagonists may offer some benefit acutely, though their role in this setting is less established than in maintenance therapy.
Acute COPD exacerbation
- Short-acting bronchodilators (β2-agonist + ipratropium), systemic corticosteroids, and antibiotics (e.g., doxycycline) when infection is suspected — doxycycline's anti-inflammatory properties are useful even without confirmed infection.
Aspirin-Exacerbated Respiratory Disease Mechanism
Leukotriene Synthesis Pathway
- LTB4 is a potent neutrophil chemoattractant and promotes leukocyte adhesion — it drives inflammatory cell recruitment rather than bronchoconstriction directly.
- LTC4, LTD4, LTE4 (collectively the components of what was historically called slow-reacting substance of anaphylaxis) are the leukotrienes responsible for bronchoconstriction, increased vascular permeability, and mucus secretion — the targets of leukotriene receptor antagonists like montelukast.
Zileuton blocks leukotriene synthesis entirely (upstream, affecting LTB4 and LTC4/D4/E4 alike), while montelukast only blocks the receptor for the cysteinyl leukotrienes (LTC4/D4/E4) — so montelukast leaves LTB4-driven neutrophil chemotaxis untouched, which is why the two drugs aren't interchangeable despite acting on the same pathway.
β-Agonist Potency & Special Clinical Uses
- Relative potency at β-receptors (most → least potent): isoproterenol > epinephrine > norepinephrine.
- Because inhaled therapy limits systemic exposure, meaningful systemic β2 activation is uncommon — but when it occurs, it can cause vasodilation, a modest fall in peripheral vascular resistance, increased skeletal muscle and hepatic glycogenolysis, increased glucagon release, and relaxation of uterine smooth muscle.
- β2-selective agents have a niche use outside the lung: terbutaline can be used off-label to relax uterine smooth muscle and delay preterm labor (tocolysis), exploiting that same systemic effect.
"Triple therapy" for COPD with persistent symptoms or exacerbations combines an inhaled corticosteroid, a long-acting β₂-agonist, and a long-acting muscarinic antagonist — each targets a different part of the pathway (inflammation, bronchodilation via cAMP, and bronchodilation via blocked vagal tone, respectively), which is why the combination outperforms any single class.
🦠 Pneumonia
The V/Q mismatch created when alveoli fill with inflammatory exudate — the physiologic reason pneumonia causes hypoxemia — is covered with Ventilation–Perfusion Relationships & Gas Exchange → Approach to Hypoxemia.
Pathogenesis
- Most cases arise from microaspiration of oropharyngeal flora or inhalation of infectious droplets; less commonly via hematogenous spread, direct contiguous spread, or traumatic inoculation.
- Normal oral flora is dominated by gram-positive cocci; hospitalized patients are often colonized instead by gram-negative rods, which is why nosocomial pneumonia has a different typical organism profile than community-acquired disease.
- Risk is increased by anything that impairs airway protection or clearance — alcoholism, nasogastric tube placement, and any cause of obtundation.
Typical vs Atypical Presentation
| Typical | Atypical | |
|---|---|---|
| Onset | Abrupt | Gradual, insidious |
| Fever | High | Low-grade |
| Cough | Productive, purulent sputum | Dry / non-productive |
| Imaging | Focal lobar consolidation | Diffuse, patchy interstitial infiltrate |
| Underlying mechanism | Alveolar-filling exudate of neutrophils/bacteria | Interstitial inflammation from intracellular organisms — less alveolar exudate, hence a drier cough |
| Classic organisms | S. pneumoniae, S. aureus, Klebsiella | Mycoplasma, Chlamydophila, Legionella, respiratory viruses |
Pattern of Lung Involvement
- Lobar: dense, confluent consolidation of an entire lobe — classic for S. pneumoniae.
- Bronchopneumonia: patchy, multifocal consolidation centered on airways — S. aureus, H. influenzae, gram-negative rods.
- Interstitial ("walking") pneumonia: inflammation confined largely to alveolar septa — atypical organisms and viruses.
Organism Pearls
| Organism | Distinguishing Clue |
|---|---|
| Streptococcus pneumoniae | Most common cause of community-acquired pneumonia overall |
| Streptococcus agalactiae (Group B strep) | Classic neonatal pathogen; clinical picture resembles S. pneumoniae infection |
| Haemophilus influenzae | Especially in the elderly; often complicates an underlying viral infection or chronic respiratory disease |
| Mycoplasma pneumoniae | Most common atypical cause in young adults; positive cold agglutinins; lacks a cell wall (β-lactams ineffective) |
| Legionella pneumophila | Water source exposure (cooling towers, plumbing); GI symptoms, hyponatremia, confusion |
| Chlamydophila pneumoniae | Young adults; can cause both upper and lower respiratory tract infection |
| Chlamydophila psittaci | Bird exposure; can cause splenomegaly, relative bradycardia |
| Chlamydia trachomatis | Neonatal pneumonia acquired during delivery; the same organism also causes trachoma, a chlamydial conjunctivitis that can progress to blindness |
| Klebsiella pneumoniae | Alcoholics, aspiration; thick "currant jelly" sputum; often causes abscess/cavitation |
| Staphylococcus aureus | Post-influenza secondary bacterial pneumonia; abscess formation |
| Pseudomonas aeruginosa | Ventilator-associated, cystic fibrosis, immunocompromised hosts |
| Pneumocystis jirovecii | Opportunistic in advanced HIV/immunosuppression; diffuse ground-glass infiltrate; now classified as a fungus |
Natural History of Lobar Pneumonia
| Stage | Timing | What's happening |
|---|---|---|
| Congestion | Days 1–2 | Vascular engorgement and early exudate, mostly bacteria — partial, patchy consolidation |
| Red hepatization | Days 3–4 | Alveoli fill with red cells, neutrophils, and fibrin — lung takes on a firm, liver-like (red) texture; still reversible at this point |
| Gray hepatization | Days 5–7 | Red cells break down and neutrophils/fibrin dominate — lung turns uniformly gray |
| Resolution | Day 8 onward | Macrophages enzymatically digest and clear the exudate |
Only congestion and red hepatization are still readily reversible — by gray hepatization the exudate is dominated by fibrin and dying neutrophils rather than viable organisms, which is why early antibiotic therapy shortens how much of the slow, macrophage-driven resolution phase is even needed.
Lung Abscess
- In a comatose or obtunded patient, the leading cause is aspiration pneumonia secondary to a depressed cough/gag reflex.
- Other causes: septic emboli (e.g., from infective endocarditis), direct spread from an adjacent infected structure, and obstruction/necrosis from an underlying malignant tumor.
- Typically due to anaerobes (e.g., Bacteroides, Fusobacterium, Peptostreptococcus) or S. aureus; look for an air-fluid level on imaging, which suggests cavitation.
- Location tracks patient positioning at the time of aspiration — right lower lobe if the aspiration happened while upright, right upper or middle lobe if recumbent, mirroring the general aspiration-pneumonia pattern.
- Managed with antibiotics; drainage or surgery for refractory cases.
Pneumococcal Vaccination
Pneumococcal conjugate vaccines generate a T-cell-dependent IgG response that reduces nasopharyngeal carriage of S. pneumoniae, lowering rates of invasive disease including lobar pneumonia. Newer 20-valent conjugate formulations extend serotype coverage beyond the earlier 13/15-valent versions.
Viral Pneumonia
- Respiratory syncytial virus (RSV): also a leading cause of bronchiolitis; peaks in winter months; can cause severe respiratory distress in infants.
- Influenza: frequently complicated by secondary bacterial pneumonia (classically S. aureus) as viral damage to the respiratory epithelium predisposes to bacterial superinfection.
Fungal Pneumonias by Geography
- Histoplasma capsulatum — Ohio/Mississippi River valleys; intracellular in macrophages.
- Coccidioides immitis — Southwestern US deserts ("valley fever"); spherules filled with endospores.
- Blastomyces dermatitidis — Great Lakes/Mississippi-Ohio basins; broad-based budding yeast.
- Paracoccidioides brasiliensis — Central and South America; budding yeast forms with a characteristic "captain's wheel" (multiple peripheral buds) appearance.
- Aspergillus — forms a fungus ball (aspergilloma) in pre-existing cavities, or invasive disease in the severely immunocompromised.
- Cryptococcus neoformans — encapsulated yeast; especially important as a cause of meningitis in immunocompromised hosts.
- Sporotrichosis — not primarily a pneumonia but a skin/lymphatic infection classically affecting rose gardeners after a thorn prick; included here as a fungal exposure pearl.
Most Common Pathogens by Age Group
| Age Group | Typical Organisms |
|---|---|
| Neonates | Group B streptococcus, E. coli |
| Children | Respiratory viruses (RSV, parainfluenza, influenza), S. pneumoniae |
| Young adults | Mycoplasma pneumoniae, S. pneumoniae |
| Older adults (40–60) | S. pneumoniae, H. influenzae, anaerobes |
| Elderly | S. pneumoniae, gram-negative rods, anaerobes |
Aspirin given for fever during influenza or varicella infection in children carries a risk of Reye syndrome — a potentially fatal combination of encephalopathy and hepatic dysfunction. Use acetaminophen instead in this population.
🧫 Tuberculosis
Silica-laden macrophages have impaired antimycobacterial function, which is why silicosis is a recognized risk factor for TB reactivation — covered with Interstitial & Occupational Lung Disease → Occupational Lung Disease (Pneumoconiosis).
Primary vs Secondary (Reactivation) TB
Primary TB
- Initial infection, usually in the lower/mid lung zones (better ventilated in a first exposure).
- Granuloma with central caseous necrosis + regional hilar lymph node involvement = Ghon complex.
- Usually contained by cell-mediated immunity; often clinically silent, heals with calcification.
Secondary (reactivation) TB
- Reactivation of latent bacilli, typically when immunity wanes.
- Accounts for the majority of newly diagnosed adult pulmonary TB — roughly 70-80% of new cases represent reactivation of a clinically silent infection acquired years to decades earlier, rather than new primary infection.
- Favors the apical/upper lobes — higher regional oxygen tension favors this obligate aerobe.
- Cavitary lesions, can rupture into a bronchus (spreading infection) or disseminate hematogenously (miliary TB — innumerable small seed-like lesions).
Primary and secondary TB are the same organism producing opposite location patterns for the same reason — the initial exposure colonizes the better-ventilated lower/mid zones, while reactivation favors the apex because it's the most oxygen-rich environment for this obligate aerobe once cell-mediated immunity has already contained the original site.
- Presentation: fever, night sweats, weight loss, hemoptysis, chronic cough.
- Acid-fast bacillus — the thick, lipid- and mycolic-acid-rich cell wall resists standard Gram staining and retains carbol-fuchsin dye despite acid-alcohol decolorization.
- Extrapulmonary reactivation sites to remember: vertebral bodies (Pott disease), meninges, kidneys, adrenal glands, and the psoas major muscle (often via direct spread from vertebral disease).
First-Line Anti-TB Therapy (RIPE)
Standard regimen: all four RIPE drugs together for an initial 2-month intensive phase, followed by isoniazid + rifampin alone for a continuation phase of roughly 4 to 7 more months, depending on clinical response.
| Drug | Mechanism | Key Toxicity |
|---|---|---|
| Rifampin | Inhibits DNA-dependent RNA polymerase | Induces CYP450 (many drug interactions), orange-red body fluids, hepatotoxicity |
| Isoniazid (INH) | Inhibits mycolic acid synthesis (cell wall); diffuses freely into essentially all body fluids, including breast milk | Peripheral neuropathy (prevent with pyridoxine/B6), hepatotoxicity |
| Pyrazinamide | Mechanism not fully defined; active in acidic (phagolysosomal) environment | Hepatotoxicity, hyperuricemia |
| Ethambutol | Inhibits arabinosyltransferase (cell wall synthesis) | Optic neuritis (red-green color vision loss) |
Because rifampin induces hepatic CYP450 enzymes, it accelerates the metabolism (lowers effectiveness) of many co-administered drugs, including oral contraceptives, warfarin, and antiretrovirals — always screen a TB patient's medication list.
❤️ Pulmonary Vascular Disease
The dead space concept (V/Q → ∞) that explains why pulmonary embolism causes reflex hyperventilation and a widened A–a gradient is defined with Ventilation–Perfusion Relationships & Gas Exchange → Anatomic vs Physiologic Dead Space.
Pulmonary Embolism
- Underlying risk framework — Virchow triad: venous stasis, endothelial injury, hypercoagulability.
- Most commonly embolizes from proximal deep vein thrombosis (femoral/iliac veins).
- Presentation: sudden dyspnea, pleuritic chest pain, tachycardia, tachypnea; large emboli can cause hypotension and sudden death.
- Physiology: creates dead space (high V/Q) in the affected segment → reflex hyperventilation → respiratory alkalosis; widened A–a gradient.
- A saddle embolus lodges at the main pulmonary artery bifurcation and can be rapidly fatal.
- Common clinical settings that predispose to PE: malignancy, multiple fractures/major orthopedic surgery, oral contraceptive or other estrogen use, prolonged immobilization/bed rest, and heart failure.
- When infarction does occur, it classically produces a hemorrhagic, wedge-shaped area of necrosis, because the dual (bronchial + pulmonary) blood supply to the lung makes true infarction less common than the vascular occlusion alone would suggest.
- Non-thrombotic emboli to remember: fat emboli (long bone fracture, orthopedic surgery), amniotic fluid emboli (peripartum), air emboli (central line placement, diving).
- Beyond the classic thrombus, an embolus can be composed of several other materials — worth keeping as a checklist when a patient doesn't fit the typical DVT-to-PE story: fat (long-bone fracture, liposuction; triad of hypoxemia, neurologic changes, petechial rash), air (decompression sickness in divers, or iatrogenic from line placement — treated with hyperbaric O₂), bacteria (septic emboli), amniotic fluid (labor/postpartum — can trigger DIC), and tumor fragments.
- On gross pathology, a thrombus formed before death shows alternating pale (platelet/fibrin) and red (red cell) laminations known as lines of Zahn — useful for distinguishing an antemortem thrombus from a postmortem clot, which lacks this layered pattern.
- Treatment: anticoagulation (heparin, or a direct thrombin/factor Xa inhibitor) is first-line; an IVC filter is reserved for patients in whom anticoagulation is contraindicated.
PE is the textbook cause of dead space physiology (V/Q → ∞) rather than shunt, which is exactly why supplemental oxygen does meaningfully improve the resulting hypoxemia — a useful way to separate PE from the shunt physiology of severe pneumonia or ARDS on a hypoxemia question.
Hypoxic Pulmonary Vasoconstriction
- Unique to the pulmonary circulation: local alveolar hypoxia triggers vasoconstriction (opposite of systemic circulation, where hypoxia causes vasodilation).
- Physiologic purpose: diverts blood flow away from poorly ventilated lung units toward better-ventilated ones, optimizing overall V/Q matching.
- Global alveolar hypoxia (e.g., high altitude, severe COPD) causes diffuse pulmonary vasoconstriction → chronic pulmonary hypertension → right heart strain.
Pulmonary Hypertension
- Primary: idiopathic proliferation of pulmonary vascular smooth muscle.
- Secondary: far more common — driven by chronic hypoxia (COPD, high altitude), left heart disease, chronic thromboembolism, or chronically increased pulmonary blood flow, as seen with a left-to-right cardiac shunt.
- Chronic pressure overload of the right ventricle → right ventricular hypertrophy → eventual right heart failure, termed cor pulmonale.
- Exam findings reflect that right ventricular pressure overload: a loud P2 (pulmonic component of S2) and a left parasternal heave from the hypertrophied right ventricle.
Pulmonary Hypertension — Etiologic Groups
| Group | Category | Examples |
|---|---|---|
| 1 | Pulmonary arterial hypertension | Idiopathic (more common in women, often a poor-prognosis heritable form), connective tissue disease, HIV, portal hypertension, congenital heart disease, certain drugs (amphetamines, cocaine) |
| 2 | Left heart disease | Systolic/diastolic dysfunction, valvular disease |
| 3 | Chronic lung disease/hypoxia | COPD, interstitial lung disease, obstructive sleep apnea, high altitude |
| 4 | Chronic thromboembolic disease | Recurrent, unresolved microthrombi narrowing the pulmonary vascular bed |
| 5 | Multifactorial/unclear | Hematologic, systemic, and metabolic disorders; extrinsic vascular compression by a tumor |
The five WHO groups separate pulmonary hypertension by where the primary problem sits — the pulmonary arterioles themselves, backpressure from the left heart, chronic hypoxic vasoconstriction, mechanical thrombus obstruction, or none of the above — which is why treatment doesn't transfer across groups: vasodilators that help Group 1 disease can worsen Group 2 or 3 disease.
Targeted Pulmonary Arterial Hypertension Therapy
Group 1 disease reflects endothelial dysfunction along three vasoactive pathways — each is a distinct drug target.
| Class | Mechanism | Notes/agents |
|---|---|---|
| Endothelin receptor antagonists | Block endothelin-1-mediated vasoconstriction | Bosentan; monitor liver function (hepatotoxic) |
| PDE-5 inhibitors | ↑ cGMP → prolong the vasodilatory effect of nitric oxide | Sildenafil; contraindicated with nitrates (risk of severe hypotension) |
| Prostacyclin analogs | Direct vasodilation + inhibit platelet aggregation | Epoprostenol, iloprost; adverse effects include flushing and jaw pain |
| Activin signaling inhibitor | Fusion protein that traps TGF-β superfamily ligands → reduces pathologic pulmonary arteriolar remodeling | Sotatercept; watch for rising Hb/thrombocytopenia and bleeding risk, and it is teratogenic |
Mediastinal Masses & Mediastinitis
- Mass location narrows the differential: anterior mediastinal masses trend toward thymoma, teratoma, and lymphoma (plus retrosternal thyroid); middle mediastinal masses include lymph node metastases, bronchogenic cysts, and hiatal hernia; posterior masses trend toward neurogenic tumors and esophageal pathology.
- Acute mediastinitis is most often postoperative (cardiothoracic surgery) or follows esophageal perforation; presents with fever, chest pain, and wound drainage.
- Pneumomediastinum: air tracks into the mediastinum, usually from a ruptured alveolus or bleb dissecting along the bronchovascular sheaths; presents with chest pain and often crepitus felt/heard over the precordium on exam.
Pleural Effusion
- Fluid accumulating between the visceral and parietal pleura restricts lung expansion; Light's criteria classify the fluid as an exudate if the pleural-to-serum protein ratio exceeds 0.5, the pleural-to-serum LDH ratio exceeds 0.6, or the pleural LDH exceeds two-thirds of the upper limit of normal serum LDH.
- Exudate (cellular, cloudy): driven by local processes that increase capillary permeability — infection, malignancy, connective tissue disease, or lymphatic obstruction (chylothorax); often needs drainage given the higher infection risk.
- Transudate (hypocellular, clear): driven by systemic pressure imbalances — ↑ hydrostatic pressure (heart failure) or ↓ oncotic pressure (nephrotic syndrome, cirrhosis).
Pulmonary Edema
| Type | Mechanism | Classic Cause |
|---|---|---|
| Cardiogenic | ↑ hydrostatic pressure from left heart failure | CHF, mitral stenosis |
| Non-cardiogenic (permeability edema) | ↑ capillary permeability | ARDS, sepsis, uremia |
Chronic cardiogenic pulmonary edema produces hemosiderin-laden alveolar macrophages ("heart failure cells") from breakdown of extravasated red cells.
Granulomatosis with Polyangiitis (formerly Wegener granulomatosis)
- Small-to-medium vessel necrotizing vasculitis of unclear (likely autoimmune) etiology.
- Classic triad: upper respiratory tract necrotizing granulomas (sinusitis, nasal ulceration/saddle-nose deformity), lower respiratory tract nodules/cavitation, and rapidly progressive (pauci-immune) glomerulonephritis.
- Serology: c-ANCA (anti-proteinase 3) positive in the great majority of cases.
- Untreated disease has a high mortality; immunosuppressive therapy is the mainstay of treatment.
The most common causes of hemoptysis are bronchitis, malignancy, and tuberculosis; when a pleural effusion is grossly bloody, the leading considerations are tuberculosis, malignancy, and trauma. Pulmonary embolism/infarction and Goodpasture syndrome are additional causes worth keeping on the differential for hemoptysis.
🎗️ Lung Neoplasms
Lung cancer is the leading cause of cancer death for both sexes, despite not being the most commonly diagnosed cancer overall — it ranks second in incidence behind prostate cancer in men and breast cancer in women. Lung cancer mortality among women has been rising as a reflection of historical smoking trends in that population.
Central vs Peripheral Location — a Useful Organizing Principle
Central tumors
- Squamous cell carcinoma — strongly smoking-associated; keratin pearls, intercellular bridges on histology; can cavitate; associated with PTHrP-mediated hypercalcemia.
- Small cell carcinoma — most aggressive; neuroendocrine origin (arises from Kulchitsky cells); strongly smoking-associated; often metastatic at diagnosis (surgery rarely indicated); associated with ectopic ACTH (Cushing syndrome) and ADH (SIADH) secretion, and Lambert-Eaton myasthenic syndrome. Histology shows sheets of small, dark, undifferentiated cells that stain positive for neuroendocrine markers (chromogranin A, synaptophysin, neuron-specific enolase); amplification of myc-family oncogenes is common.
Peripheral tumors
- Adenocarcinoma — most common lung cancer overall, including in never-smokers, and more common in women than men; often arises in areas of prior scarring; glandular architecture that frequently stains mucin-positive; associated with KRAS, EGFR, and ALK mutations (the latter two are targetable with specific inhibitors). Also associated with hypertrophic osteoarthropathy (clubbing plus periosteal new bone formation).
- Bronchioloalveolar carcinoma — a distinct subtype of adenocarcinoma in which tumor cells grow along intact alveolar walls rather than forming a destructive mass, producing a pneumonia-like hazy infiltrate on imaging; carries a weaker smoking association than other subtypes and a comparatively better prognosis.
- Large cell carcinoma — highly anaplastic, undifferentiated tumor with pleomorphic giant cells on histology; strongly smoking-associated; occasionally secretes hCG, producing gynecomastia; less responsive to chemotherapy, poor prognosis.
- Carcinoid tumor — low-grade neuroendocrine tumor (nests of neuroendocrine cells, chromogranin A positive) that can arise centrally or peripherally; excellent prognosis with rare metastasis; symptoms come either from local mass effect (wheezing) or, if it metastasizes past hepatic first-pass clearance, from carcinoid syndrome (flushing, diarrhea, wheezing).
- Hamartoma — a benign lung mass, not a true cancer; typically an incidental, well-circumscribed nodule found on imaging.
Central vs peripheral location tracks the tumor's cell of origin — squamous cell and small cell arise from bronchial epithelium/neuroendocrine cells near the hilum, while adenocarcinoma arises from more distal glandular tissue — which is also why central tumors present earlier with airway symptoms (cough, hemoptysis, obstruction) and peripheral tumors are more often found incidentally.
Metastatic lung lesions (from a primary tumor elsewhere) are actually more common overall than primary lung cancer, classically appearing as multiple "cannonball" lesions on imaging — most often seeded from breast, colon, prostate, and bladder primaries. When lung cancer itself metastasizes, the classic target organs are the liver (jaundice, hepatomegaly), adrenal glands, bone (pathologic fracture), and brain.
Paraneoplastic Syndromes
| Syndrome | Mechanism | Associated Tumor |
|---|---|---|
| SIADH | Ectopic ADH secretion → hyponatremia | Small cell |
| Cushing syndrome | Ectopic ACTH secretion | Small cell |
| Hypercalcemia | PTH-related peptide secretion | Squamous cell |
| Lambert-Eaton myasthenic syndrome | Antibodies against presynaptic voltage-gated calcium channels | Small cell |
| Horner syndrome | Apical (Pancoast) tumor compresses the sympathetic chain | Any apical tumor, classically squamous cell |
Horner syndrome = ptosis + miosis + anhidrosis, from disruption of the sympathetic pathway. Superior vena cava syndrome (facial swelling, distended neck veins) is a related but mechanistically distinct complication of apical/mediastinal tumors from direct venous compression rather than sympathetic chain injury.
Pancoast Tumor & Superior Vena Cava Syndrome
- A Pancoast (superior sulcus) tumor arises at the lung apex and produces its effects by invading or compressing nearby structures rather than through distant metastasis: the recurrent laryngeal nerve (hoarseness), the sympathetic (stellate) ganglion (Horner syndrome), the brachial plexus (shoulder pain, hand muscle weakness/atrophy), and the phrenic nerve (hemidiaphragm elevation on imaging).
- Superior vena cava syndrome: obstruction of the SVC — by direct tumor invasion (Pancoast tumor, mediastinal mass) or by thrombus from an indwelling catheter — impairs venous drainage from the head, neck, and upper extremities. Presents with facial swelling/plethora, jugular venous distension, and upper-extremity edema; treated as a medical emergency because severe obstruction can raise intracranial pressure.
A helpful way to organize the many local complications of lung cancer: SVC/thoracic outlet compression, Pancoast tumor, Horner syndrome, Endocrine (paraneoplastic) effects, Recurrent laryngeal nerve compression (hoarseness), and pleural or pericardial Effusions.
Risk Factors & Digital Clubbing
- Tobacco smoking is by far the dominant risk factor; also secondhand smoke, radiation exposure, environmental/occupational exposures (radon, asbestos), pre-existing pulmonary fibrosis, and family history.
- Digital clubbing (widened nail-bed angle >180°) reflects local release of growth factors (e.g., PDGF, VEGF) from platelets/megakaryocytes lodged in the distal digital vasculature, most often in the setting of an intrapulmonary shunt. Beyond lung cancer, it's seen with other chronic pulmonary disease (idiopathic pulmonary fibrosis, cystic fibrosis, bronchiectasis), cyanotic congenital heart disease, and chronic infection (lung abscess, TB) — notably, it is not a typical feature of plain COPD or asthma.
Other Respiratory Tract Carcinomas
| Tumor | Histology | Risk Factors |
|---|---|---|
| Nasopharyngeal carcinoma | Lymphoepithelioma — undifferentiated epithelial cells with a dense lymphocytic infiltrate | Epstein-Barr virus infection; endemic in Southeast Asia (adults) and parts of Africa (children) |
| Laryngeal carcinoma | Squamous cell carcinoma | Smoking (and synergistically, alcohol use) |
| Laryngeal papillomatosis | Benign squamous papilloma of the true vocal cords | HPV-6 and HPV-11; in children, thought to be acquired from an infected mother during vaginal delivery — presents with hoarseness or, if more supraglottic, dysphagia |
Most head and neck cancer is squamous cell carcinoma, driven by tobacco, alcohol, and — depending on the exact site — HPV-16 (oropharyngeal) or EBV (nasopharyngeal). "Field cancerization" describes how a broad area of mucosa exposed to the same carcinogen can develop multiple, independent primary tumors rather than one tumor spreading locally.
🔄 Ventilation–Perfusion Relationships & Gas Exchange
Regional V/Q Gradient (Upright Lung)
| Zone | Blood flow | Ventilation | Net V/Q | Why |
|---|---|---|---|---|
| Apex (Zone 1) | Lowest | Relatively higher | High (>1) | Gravity minimizes perfusion at the apex more than it minimizes ventilation |
| Base (Zone 3) | Highest | Relatively lower | Low (<1) | Gravity pools blood at the base; alveoli there are already less compliant (partially collapsed at rest) |
- Whole-lung average V/Q ≈ 0.8 (ventilation slightly exceeds perfusion overall).
- A middle Zone 2 exists between apex and base, where arterial pressure exceeds alveolar pressure, which in turn exceeds venous pressure — capillaries stay open throughout the cardiac cycle and ventilation and perfusion are roughly matched (V/Q ≈ 1).
- During exercise, increased cardiac output raises pulmonary vascular pressures enough to recruit and distend capillaries throughout the lung, making the V/Q ratio much more uniform from apex to base.
- V/Q → 0 (perfusion without ventilation) = physiologic shunt — e.g., complete airway obstruction, atelectasis. Does not correct with supplemental oxygen because the blood never contacts ventilated alveoli.
- V/Q → ∞ (ventilation without perfusion) = physiologic dead space — e.g., pulmonary embolism. Wastes ventilation on alveoli with no blood flow to pick up the oxygen.
Shunt and dead space sit at opposite ends of the same V/Q spectrum — perfused-but-unventilated lung versus ventilated-but-unperfused lung — and that asymmetry is exactly why only shunt fails to respond to supplemental oxygen: dead space alveoli are still ventilated and can be recruited elsewhere in the lung, but shunted blood never contacts oxygenated air at all.
Anatomic Shunts
- Blood that passes from the venous to the arterial circulation without traversing ventilated alveoli — a normal, small contributor to the resting A–a gradient (roughly 2% of cardiac output, largely via bronchial and thebesian venous drainage).
- Pathologic right-to-left shunting can raise this fraction dramatically — up to roughly 50% of cardiac output in severe congenital lesions such as tetralogy of Fallot — and, like any true shunt, does not correct with supplemental oxygen.
Anatomic vs Physiologic Dead Space
- Anatomic dead space: the conducting airways (nose through terminal bronchioles) that carry air but never participate in gas exchange; measured by the Fowler method (tracking nitrogen washout during a single exhaled breath).
- Physiologic dead space: anatomic dead space plus any ventilated-but-underperfused alveoli that fail to eliminate CO2 effectively; measured by the Bohr method, using the relationship:
where Vd = physiologic dead space, Vt = tidal volume, PaCO2 = arterial CO2, and PECO2 = mixed expired CO2. In a healthy lung the two dead-space values are nearly equal; a widening gap between them signals V/Q mismatch from poorly perfused (but ventilated) alveolar units.
Hypoxic pulmonary vasoconstriction — the mechanism linking chronic alveolar hypoxia to pulmonary hypertension — is covered with Pulmonary Vascular Disease → Pulmonary Hypertension.
Approach to Hypoxemia
| Mechanism | A–a Gradient | Responds to Supplemental O₂? | Classic Example |
|---|---|---|---|
| Hypoventilation | Normal | Yes | Opioid overdose, neuromuscular weakness |
| Low inspired FiO₂ | Normal | Yes | High altitude |
| V/Q mismatch | Increased | Yes (gradient improves) | Pneumonia, COPD, PE |
| Diffusion limitation | Increased | Partial (gradient persists) | Interstitial lung disease |
| Right-to-left shunt | Increased | No (minimal change) | Cyanotic congenital heart disease, severe atelectasis |
A shunt is the one hypoxemia mechanism that does not meaningfully improve with 100% oxygen — a fast way to distinguish it from V/Q mismatch on test questions.
Diffusion-Limited vs Perfusion-Limited Gas Exchange
| Pattern | Gases | What's happening |
|---|---|---|
| Perfusion-limited | O₂ (in a healthy lung), CO₂, N₂O | Gas equilibrates fully across the capillary well before blood reaches its end — the only way to increase total gas transfer is to increase blood flow |
| Diffusion-limited | O₂ (in emphysema or fibrosis), carbon monoxide | Gas fails to equilibrate by the time blood exits the capillary — transfer stays limited by the properties of the membrane itself |
- Carbon monoxide is deliberately diffusion-limited under normal conditions (its capillary partial pressure essentially never rises high enough to equilibrate) which is exactly why it makes a convenient tracer gas for measuring diffusing capacity (DLCO) clinically.
- Diseases that thicken or destroy the alveolar-capillary membrane (pulmonary fibrosis, emphysema) push oxygen transfer from the perfusion-limited into the diffusion-limited regime — this is the mechanistic reason those diseases tend to cause hypoxia on exertion before they cause resting hypoxia.
Alveolar Gas Equation
- At sea level, atmospheric pressure ≈ 760 mmHg and the water vapor pressure of fully humidified alveolar air ≈ 47 mmHg.
- FiO2 is the fraction of inspired air that is oxygen (0.21 on room air); 0.8 is the respiratory quotient (CO2 produced per O2 consumed).
- Used to calculate the expected alveolar oxygen tension, which is then compared to the measured arterial oxygen tension to compute the A–a gradient.
Room air has a much higher oxygen tension (~160 mmHg) and essentially no CO2 (~0 mmHg) compared to typical arterial blood gas values (PO2 ~100 mmHg, PCO2 ~40 mmHg) — the difference between inspired and alveolar/arterial values reflects gas exchange and humidification occurring within the lung itself.
Ventilation Equation
Rearranged, this means alveolar PCO2 varies inversely with alveolar ventilation for a fixed rate of CO2 production — for example, if CO2 production is unchanged, a threefold rise in expired PCO2 implies alveolar ventilation has fallen to a third of its prior value.
The three-layer structure of the blood–air barrier, and how ARDS damages it, is covered with Acute Respiratory Distress Syndrome (ARDS).
Crossing the blood-air barrier is only half of oxygen delivery — the total amount of oxygen actually delivered to the tissues also depends on hemoglobin concentration and red cell number (hematocrit), which is why anemia can produce tissue hypoxia even with a structurally normal blood-air barrier and a normal PaO2.
🩸 Hemoglobin & Gas Transport
Hemoglobin Structure & Cooperative Binding
- Adult hemoglobin (HbA) is a tetramer of 2 α- and 2 β-globin chains, each carrying a heme group that binds one O₂ molecule (4 O₂ per Hb).
- Positive cooperativity: binding of the first O₂ molecule increases the affinity of the remaining subunits for O₂, producing the classic sigmoidal oxygen-hemoglobin dissociation curve. Myoglobin, by contrast, is a single-chain protein with no cooperativity — its dissociation curve is a simple hyperbola, and its higher, fixed affinity for O₂ suits its role as an O₂ reservoir in muscle rather than a transport molecule.
Oxygen Content of Blood
The first term (Hb bound) dominates total content; the second term (O₂ dissolved in plasma) is tiny by comparison. Total O₂ delivery to tissue = cardiac output × O₂ content — so a fall in cardiac output can cause tissue hypoxia even with completely normal blood gas values.
| Condition | Hb concentration | SaO₂ | PaO₂ | Total O₂ content |
|---|---|---|---|---|
| Anemia | ↓ | Normal | Normal | ↓ |
| Polycythemia | ↑ | Normal | Normal | ↑ |
| CO poisoning | Normal | ↓ (CO occupies binding sites) | Normal | ↓ |
| Methemoglobinemia | Normal | ↓ (Fe³⁺ binds O₂ poorly) | Normal | ↓ |
| Cyanide toxicity | Normal | Normal | Normal | Normal (the problem is downstream, at the mitochondria — see below) |
The oxygen content equation explains why anemia, CO poisoning, and methemoglobinemia all cause tissue hypoxia despite a normal PaO2 — each reduces the effective amount of O2 hemoglobin actually carries (the dominant term in the equation), even though the tiny dissolved-O2 term stays completely unaffected.
Pulse oximetry reads SaO₂, not total O₂ content — a patient can have a dangerously low O₂-carrying capacity (severe anemia) with a perfectly normal pulse ox reading, because the fraction of available Hb that's saturated is normal even though there isn't much Hb to begin with.
Oxyhemoglobin Dissociation Curve Shifts
Right shift — ↓ affinity, ↑ O₂ unloading
- Triggers: ↑ temperature, ↓ pH, ↑ CO₂, ↑ 2,3-BPG — all signal a metabolically active tissue that needs more O₂ delivered (the Bohr effect).
- Physiologically adaptive during exercise; occurs pathologically at high altitude (chronic ↑ 2,3-BPG).
Left shift — ↑ affinity, ↓ O₂ unloading
- Triggers: ↓ temperature, ↑ pH, ↓ 2,3-BPG, carbon monoxide, methemoglobin.
- Fetal hemoglobin sits left of maternal Hb (weaker binding of 2,3-BPG) — this higher affinity is exactly what drives O₂ transfer from mother to fetus across the placenta.
CO₂ Transport
- ~90% travels as bicarbonate — CO₂ enters the red cell, carbonic anhydrase converts it (with water) to carbonic acid, which dissociates to H⁺ and HCO₃⁻; the bicarbonate is shuttled into plasma in exchange for chloride (the "chloride shift").
- ~5% binds directly to the N-terminus of deoxygenated globin as carbaminohemoglobin; ~5% dissolves directly in plasma.
- Haldane effect: oxygenation of Hb in the lungs promotes release of H⁺, which drives the equilibrium back toward CO₂ formation — this is what allows CO₂ to be released from red cells as blood passes through the pulmonary capillaries.
Response to High Altitude & Exercise
High altitude
- ↓ barometric pressure → ↓ inspired and arterial O₂ tension → reflex ↑ ventilation → ↓ PaCO₂ → respiratory alkalosis (contributing to altitude sickness symptoms).
- Chronic adaptation: ↑ erythropoietin → ↑ hematocrit/Hb; ↑ 2,3-BPG (rightward ODC shift, more O₂ unloaded at tissue); chronic hypoxic pulmonary vasoconstriction → pulmonary hypertension and right ventricular hypertrophy over time.
Exercise
- ↑ cardiac output and pulmonary blood flow → the V/Q ratio becomes more uniform from apex to base (see V/Q & Gas Exchange).
- ↑ CO₂ production and local ↓ pH at working tissue → rightward ODC shift → more O₂ offloaded exactly where it's needed; PaO₂ and PaCO₂ themselves stay near-normal because ventilation rises to match the increased demand.
Methemoglobinemia
- Iron in Hb is normally kept in the reduced, ferrous (Fe²⁺) state. Oxidizing agents — dapsone, local anesthetics such as benzocaine, and nitrites — convert it to the ferric (Fe³⁺) state, which cannot bind O₂ effectively and also increases the O₂ affinity of the remaining normal subunits (a pathologic left shift).
- Presents with cyanosis unresponsive to supplemental oxygen and characteristically brown/chocolate-colored blood.
- Treatment: methylene blue (reduces Fe³⁺ back to Fe²⁺) plus vitamin C.
Cyanide vs Carbon Monoxide Poisoning
| Cyanide | Carbon monoxide | |
|---|---|---|
| Shared mechanism | Both impair complex IV (cytochrome c oxidase) of the electron transport chain → cells shift to anaerobic metabolism despite a normal PaO₂ and normal-appearing O₂ saturation on standard pulse oximetry | |
| Typical exposure | Industrial combustion products, certain seed/pit ingestions, nitroprusside infusion | Smoke inhalation, faulty heaters/engines, incomplete combustion — an odorless, colorless gas and a leading cause of accidental poisoning death |
| Effect on the ODC | Curve stays essentially normal — the block is at the mitochondria, not at Hb | Binds Hb with far greater affinity than O₂, displacing it and left-shifting the curve, so remaining O₂ is held tightly and under-released to tissue |
| Labs | Normal PaO₂; elevated lactate/anion-gap acidosis from anaerobic metabolism | Normal PaO₂; elevated carboxyhemoglobin measured by co-oximetry (a standard pulse oximeter cannot detect it) |
| Antidote/treatment | Hydroxocobalamin (binds cyanide directly) or sodium nitrite/thiosulfate; supplemental O₂ alone is not sufficient | High-flow (or hyperbaric) O₂ — dramatically shortens the half-life of carboxyhemoglobin by outcompeting CO for Hb binding |
Cyanide and CO share the same downstream lesion (blocked complex IV) but attack the oxygen-delivery chain at different steps — CO poisons transport (Hb binding), cyanide poisons utilization (mitochondria) — which is why pulse oximetry and PaO2 look deceptively normal in both, and why their antidotes target entirely different points in the pathway.
🧠 Control of Breathing
Blunted central chemoreceptor sensitivity to CO₂ — the reason chronic CO₂ retainers shift to a hypoxic respiratory drive — underlies the chronic hypercapnia of the "blue bloater" phenotype covered with Obstructive Lung Disease → Chronic Bronchitis.
Central Pattern Generation
- Medullary respiratory centers generate the automatic rhythm of breathing; pontine centers fine-tune the rate/depth of that rhythm.
- The medulla receives sensory input via the vagus and glossopharyngeal nerves and sends motor output via the phrenic nerve to the diaphragm and via spinal (intercostal) nerves to the intercostal and abdominal wall muscles.
- Voluntary override (breath-holding, speech) originates in the cerebral cortex and acts on the medullary pattern generator.
Muscles of Respiration
- The diaphragm does the majority of the work during quiet breathing.
- Accessory muscles — the sternocleidomastoid and the internal/external intercostals — are recruited only when ventilatory demand rises, as in exercise or respiratory disease; their use on exam is a visible sign of increased work of breathing.
Chemoreceptor Control
Central chemoreceptors
- Located near the medulla, sense CSF pH, not PaCO₂ directly.
- CO₂ (but not H⁺) crosses the blood–brain barrier freely → combines with water → carbonic acid → dissociates to H⁺ + bicarbonate → drop in CSF pH stimulates ventilation.
- The dominant driver of minute-to-minute ventilation under normal conditions.
Peripheral chemoreceptors
- Carotid bodies and aortic bodies.
- Sense arterial PaO₂, PaCO₂, and pH directly.
- Only become the dominant respiratory drive when PaO₂ falls substantially (roughly below 60 mmHg) — otherwise a minor contributor.
- Rising PaCO₂ potentiates the peripheral chemoreceptors' sensitivity to falling PaO₂, even though CO₂'s own major respiratory effect is exerted centrally rather than through this peripheral pathway.
- Arterial H⁺ also stimulates the peripheral chemoreceptors directly, independent of any change in PaCO₂ — the mechanism behind the compensatory hyperventilation seen in primary metabolic acidosis.
Central and peripheral chemoreceptors sense different things by design — central receptors read CSF pH as an indirect but very sensitive proxy for PaCO2 (CO2 crosses the blood-brain barrier freely, H+ doesn't), while peripheral receptors read PaO2 directly — which is why CO2 dominates day-to-day ventilatory control but only hypoxia, via the peripheral pathway, can rescue ventilation once central CO2 sensitivity is blunted.
In chronic CO₂ retainers (e.g., severe COPD), the central chemoreceptors become desensitized to chronically elevated CO₂; hypoxia via the peripheral chemoreceptors becomes the primary respiratory drive. Giving high-flow oxygen can blunt that hypoxic drive and precipitate hypoventilation — though the more clinically important reasons for CO₂ rise with oxygen therapy include changes in V/Q matching and the Haldane effect, not drive suppression alone.
Reflex Inhibition of Inspiration
- Irritant receptors in the large airways and stretch receptors in the small airways, when activated, send inhibitory signals that terminate inspiration — a protective reflex limiting excessive lung distension.
Abnormal Breathing Patterns
- Cheyne–Stokes breathing: cyclic crescendo–decrescendo tidal volumes separated by apnea; reflects pontine dysfunction and is associated with heart failure, drug overdose, CNS depression, and elevated intracranial pressure.
- Kussmaul breathing: deep, rapid, labored breathing that is the respiratory compensation for severe metabolic acidosis (e.g., DKA) — "blowing off" CO₂ to raise pH.
- Biot's (ataxic) breathing: irregular breaths with unpredictable pauses; associated with medullary damage — poor prognostic sign.
Sleep-Disordered Breathing
Obstructive sleep apnea
- Upper airway collapses despite ongoing respiratory effort.
- Risk factors: middle age, male sex, obesity, smoking, hypertension, pharyngeal malformations, alcohol and other drug use.
- Airway obstruction most often occurs in the naso- or oropharynx as muscle tone relaxes during REM sleep; each apneic episode typically ends with a brief self-arousal that restores airway tone.
- First-line treatment: weight loss + continuous positive airway pressure (CPAP).
Central sleep apnea
- Absent respiratory effort — the drive to breathe transiently fails, with no airway obstruction and no self-arousal, distinguishing it mechanistically from OSA.
- Like obstructive sleep apnea, episodes cluster during REM sleep.
- CO₂-threshold dependent — reflects reduced central chemoreceptor sensitivity to CO₂ (and O₂), unlike the mechanical airway problem of obstructive sleep apnea.
- Associated with heart failure, opioid use, high altitude, brainstem lesions.
OSA and central sleep apnea can look identical on a sleep study (recurrent apneas, nocturnal hypoxia) but diverge on respiratory effort — present but ineffective in OSA (mechanical obstruction) versus absent in central sleep apnea (failed drive) — the single finding that separates an airway problem from a chemoreceptor/drive problem.
Multiple pharmacologic agents have been tried for sleep apnea, but none rival CPAP in effectiveness.
- Diagnosis of either type is confirmed by a formal sleep study (polysomnography).
- Repeated nocturnal hypoxia from either type of sleep apnea drives systemic and pulmonary hypertension, atrial arrhythmias, and an increased risk of sudden death; the chronic hypoxic stimulus also raises erythropoietin release, producing secondary erythrocytosis over time.
- Additional OSA treatment options beyond weight loss/CPAP: oral appliances that reposition the jaw, hypoglossal nerve stimulation, and upper airway surgery for refractory cases.
Obesity Hypoventilation Syndrome
- Also called Pickwickian syndrome; defined by obesity (BMI ≥ 30) plus chronic daytime hypoventilation — an elevated waking PaCO₂ (with a compensatory drop in PaO₂) that isn't explained by another lung or neuromuscular cause.
- Gas exchange worsens further during sleep, and the syndrome frequently coexists with obstructive sleep apnea.
- Treatment mirrors OSA: weight loss and positive airway pressure support.
🛡️ Lung Defense Mechanisms
Particle Deposition by Size
| Particle Size | Dominant Deposition Mechanism | Typical Site |
|---|---|---|
| >10 µm | Inertial impaction (too large to follow airflow around turns) | Nasopharynx |
| 2–10 µm | Sedimentation (settle under gravity as flow slows) | Bronchi / small airways |
| 0.5–2 µm | Diffusion, phagocytosed by macrophages | Alveoli |
| <0.5 µm | Remain suspended — often exhaled without depositing | N/A |
Breathing pattern shifts where particles land: slow, deep breaths favor sedimentation and diffusion (more distal deposition), while the higher airflow rates of exercise favor inertial impaction (more proximal deposition).
Particle size sets a mechanistic ceiling on how deep inhaled material can travel — large particles can't navigate the pharyngeal turns, mid-sized particles need slowed airflow to settle out, and only sub-micron particles diffuse far enough to reach the alveoli — which is why different occupational lung diseases track specific particle sizes as much as specific substances.
Mechanical & Cellular Defenses
- Mucociliary escalator: ciliated pseudostratified epithelium sweeps trapped particles in mucus toward the pharynx to be swallowed or expectorated.
- Cough reflex: rapid, forceful expiration triggered by irritant receptors; can be suppressed by opioid antitussives.
- Alveolar macrophages: phagocytose particulates and organisms that reach the alveoli; "dust cells" filled with carbon pigment reflect chronic particulate exposure.
- Secretory IgA and complement: humoral defenses within airway secretions that provide first-line mucosal protection against inhaled pathogens.
Anatomic Predisposition to Aspiration
- The right main bronchus is wider, shorter, and more vertically oriented than the left — it branches off the trachea at a shallower angle.
- This makes it the preferential path for aspirated foreign material, whether liquid, food, or a dislodged object.
- In a supine patient, aspirated material tends to settle into the right lower lobe specifically, following gravity down the more direct right-sided airway.
Primary ciliary dyskinesia (an autosomal recessive dynein-arm defect) impairs the mucociliary escalator, causing recurrent sinopulmonary infections, bronchiectasis, infertility, and — when it also disrupts embryonic nodal cilia — situs inversus.
📊 Lung Volumes, Compliance & Pulmonary Function Tests
Static Lung Volumes (building blocks)
| Volume | Definition | Directly Measured by Spirometry? |
|---|---|---|
| Tidal volume (TV) | Air moved in one normal, quiet breath | Yes |
| Inspiratory reserve volume (IRV) | Extra air inhaled beyond a normal tidal breath | Yes |
| Expiratory reserve volume (ERV) | Extra air exhaled beyond a normal tidal breath | Yes |
| Residual volume (RV) | Air remaining after maximal exhalation | No — cannot be exhaled, so spirometry can't capture it |
Derived Capacities (sums of ≥2 volumes)
- Vital capacity (VC) = IRV + TV + ERV — the maximum air that can be moved in a single breath.
- Inspiratory capacity (IC) = TV + IRV.
- Functional residual capacity (FRC) = ERV + RV — the lung volume at the end of a normal, passive exhalation.
- Total lung capacity (TLC) = VC + RV — everything.
- Any capacity that includes RV (FRC, TLC) cannot be measured by spirometry alone — requires helium dilution, nitrogen washout, or body plethysmography.
"Vital capacity" and "total lung capacity" are frequently confused — VC excludes RV, TLC includes it.
Compliance
- Describes how easily the lung–chest wall system expands for a given change in pressure; the slope of the pressure–volume curve.
- At FRC, the lung's inward elastic recoil (tendency to collapse) exactly balances the chest wall's outward recoil (tendency to spring open) → net system pressure = atmospheric, no airflow.
- Breathing above FRC (inhaling) generates positive airway pressure relative to that baseline, while breathing below FRC (forced exhalation) generates negative airway pressure — FRC is the true zero-pressure reference point for the respiratory system, not empty lungs.
↓ Compliance (stiff lung)
- Pulmonary fibrosis (any cause, including asbestosis, sarcoidosis, and ARDS)
- Pulmonary edema
- Neuromuscular weakness / chest wall restriction
- Requires more pressure change to move the same volume — steeper work of breathing
↑ Compliance (floppy lung)
- Emphysema (loss of elastic fibers)
- Normal aging
- Acute bronchospasm, as in asthma
- Lung moves easily for small pressure changes, but loses recoil needed to passively push air out — air trapping results
Restrictive and obstructive disease sit at opposite ends of the compliance spectrum — restrictive disease needs more pressure to move the same volume (stiff, low-compliance lung), obstructive disease moves volume too easily but can't push it back out (floppy, high-compliance lung with lost recoil) — this compliance framing is the physiologic root of the volume and flow patterns tested on spirometry.
Poiseuille Relationship
A small reduction in airway radius produces a dramatic rise in resistance — the physiologic basis for why bronchoconstriction (asthma) causes such disproportionate symptoms.
- Parasympathetic (vagal) tone → bronchoconstriction + increased mucus secretion (muscarinic receptors); target of anticholinergic bronchodilators. Mediated by direct vagal stimulation, airway irritation, and mast-cell-derived mediators such as histamine and the leukotriene mixture historically termed slow-reacting substance of anaphylaxis (SRS-A).
- Histamine released during allergic reactions and allergic asthma is itself a potent constrictor of airway smooth muscle and a direct contributor to airway resistance.
- Sympathetic tone (β₂ receptors) → bronchodilation; target of β₂-agonist bronchodilators.
- Airway caliber is also passively maintained by radial traction from surrounding lung parenchyma — this is why fibrotic (stiff) lungs paradoxically have low airway resistance, while emphysematous lungs (loss of parenchymal tethering) have high resistance despite large airways.
Obstructive vs Restrictive Pattern — Interpreting Spirometry
| Pattern | RV / FRC / TLC | FEV1 | FVC | FEV1/FVC |
|---|---|---|---|---|
| Obstructive (asthma, COPD) | ↑ / ↑ / ↑ (air trapping) | ↓↓ | ↓ (mild) | ↓ (<0.7) |
| Restrictive (fibrosis, chest wall/neuromuscular disease) | ↓ / ↓ / ↓ | ↓ | ↓↓ | Normal or ↑ |
On a flow-volume loop, obstructive disease characteristically scoops out the expiratory limb and shifts the whole loop leftward (toward higher lung volumes, reflecting air trapping), while restrictive disease produces a narrower loop of normal shape shifted rightward (toward lower lung volumes).
DLCO (diffusing capacity) reflects the functional gas-exchange surface area — it separates restrictive diseases caused by lung parenchyma itself from those caused by something squeezing a structurally normal lung.
🚨 Acute Respiratory Distress Syndrome (ARDS)
Structure of the Blood–Air Barrier
- Gas must cross three thin layers to move between alveolar air and pulmonary capillary blood:
- Type I pneumocyte membrane and cytoplasm (the thin, gas-permeable alveolar lining cell).
- A fused basement membrane shared by the type I pneumocyte and the capillary endothelial cell.
- Capillary endothelial cell membrane and cytoplasm.
- Any process that thickens this barrier (interstitial fibrosis, pulmonary edema) impairs diffusion and is the physiologic basis of a reduced DLCO.
The blood-air barrier's three thin layers exist in tension with gas exchange efficiency — thin enough for fast diffusion, but exactly the structure that ARDS's neutrophil-mediated injury destroys, converting a diffusion-optimized membrane into a leaky, protein-rich, edema-forming one.
- Diagnostic hallmarks: acute onset, bilateral infiltrates on imaging, hypoxemia not explained by cardiac cause, and a PaO₂/FiO₂ ratio below a defined threshold.
- Gross pathology: heavy, fluid-laden ("wet") lungs from the protein-rich edema fluid — a finding shared with NRDS.
- Barotrauma-related pneumothorax is a recognized complication that can develop rapidly and become fatal, adding to the rationale for lung-protective (low-pressure, low-volume) ventilation strategies.
- Histology: diffuse alveolar damage with hyaline membranes lining alveoli — the adult counterpart to NRDS's hyaline membranes, but driven by neutrophilic injury rather than surfactant deficiency. Hyaline membranes themselves are eosinophilic, protein-rich membranous deposits that line the alveolar walls, formed from leaked plasma proteins and cellular debris.
- Management centers on treating the underlying cause plus lung-protective mechanical ventilation (low tidal volumes to avoid ventilator-induced injury) and conservative fluid management.
ARDS and NRDS both show hyaline membranes histologically, but the underlying mechanism differs completely — neutrophil-mediated capillary injury in ARDS vs. surfactant deficiency in NRDS. Don't let the shared finding imply a shared cause.
📉 Pneumothorax & Chest Wall Trauma
Pneumothorax is a direct disruption of the normal FRC balance between inward lung recoil and outward chest wall recoil, described with Lung Volumes & Compliance → Compliance.
Simple (spontaneous) pneumothorax
- Classic patient: tall, thin, young male — spontaneous rupture of an apical bleb (which may itself be congenital or secondary to paraseptal emphysema); penetrating chest trauma is an alternate cause, in either case producing a loss of the normally negative intrathoracic pressure.
- Presents with sudden pleuritic chest pain and dyspnea.
- Exam: decreased breath sounds, hyperresonance to percussion, on the affected side.
- Management scales with size — observation for small, chest tube for larger defects.
- Carries a substantial recurrence risk, on the order of 50%, particularly if the underlying predisposing bleb is not addressed.
Tension pneumothorax
- One-way valve mechanism: air enters the pleural space on inspiration but cannot escape.
- Progressive pressure buildup pushes the mediastinum away from the affected side.
- Jugular venous distension, hypotension, and cardiovascular collapse can follow rapidly — a clinical diagnosis requiring immediate needle decompression, not imaging first.
Simple and tension pneumothorax are the same underlying injury — air breaching the pleural space — diverging only in whether that air can escape; a one-way valve turns a self-limited problem into a rapidly fatal one, which is why tension physiology is diagnosed and treated by exam findings alone, without waiting for imaging.
Tracheal Deviation Rules of Thumb
- Tension pneumothorax (a space-occupying process) pushes the trachea away from the lesion.
- Volume loss (atelectasis, complete bronchial obstruction, lobectomy) pulls the trachea toward the affected side — and because ventilation to that lung is reduced, tactile fremitus and resonance are both decreased over it, distinguishing it from the hyperresonant, decreased-fremitus exam of a pneumothorax.
Expected arterial blood gas in a significant pneumothorax: hypoxemia (↓PO₂), hypercapnia (↑PCO₂), a resulting acidosis, with a compensatory rise in bicarbonate if the process has been ongoing long enough for renal compensation.
Flail chest — segmental fractures of multiple adjacent ribs — produces paradoxical inward movement of the flail segment during inspiration and is often accompanied by underlying pulmonary contusion.
Atelectasis
- Obstructive: airway blockage (mucus plug, tumor, foreign body) prevents air from reaching distal lung; trapped air is gradually resorbed and the lung collapses — this is the type that pulls the trachea toward the affected side.
- Compressive: an external mass, effusion, or air compresses adjacent lung tissue.
- Contraction (cicatrization): scarring distorts and pulls in surrounding parenchyma (e.g., sarcoidosis, radiation fibrosis).
- Adhesive: surfactant deficiency prevents alveoli from staying open (classically neonatal respiratory distress syndrome).
- Incentive spirometry and positive end-expiratory pressure both work by keeping alveoli inflated, directly counteracting the tendency to collapse.
Physical Exam Findings Across Pleural/Airway Pathology
| Finding | Breath sounds | Percussion | Fremitus | Tracheal deviation |
|---|---|---|---|---|
| Pleural effusion | ↓ | Dull | ↓ | None if small; away from lesion if large |
| Atelectasis | ↓ | Dull | ↓ | Toward the lesion |
| Simple pneumothorax | ↓ | Hyperresonant | ↓ | None |
| Tension pneumothorax | ↓ | Hyperresonant | ↓ | Away from the lesion |
| Consolidation (lobar pneumonia) | Bronchial breath sounds, crackles, egophony | Dull | ↑ | None |
Everything on this table follows from one principle — fluid and solid tissue transmit sound better than air, so consolidation and effusion both change breath sounds and fremitus in the same direction but for opposite reasons (fluid/exudate filling the space vs. fluid displacing air out of it), while a pneumothorax's excess air does the opposite for exactly the reverse reason.
Open (Sucking) Chest Wound
- Penetrating chest wall trauma that leaves an open communication between the pleural space and the atmosphere.
- Air preferentially enters through the wound rather than the trachea whenever the defect diameter approaches or exceeds the tracheal diameter — the path of least resistance.
- Impairs effective ventilation on the affected side and can evolve into a tension physiology if the wound is incompletely occluded, so initial management typically involves a three-sided occlusive dressing that vents air out but not in.
🧵 Interstitial & Occupational Lung Disease
Shared physiology: ↓ lung volumes, normal-to-increased FEV1/FVC ratio, and (in parenchymal disease) reduced DLCO from thickened or destroyed alveolar-capillary interface.
The mechanics of ↓ compliance (the "stiff lung" pattern underlying all restrictive disease) are covered with Lung Volumes & Compliance.
Interstitial Lung Disease
| Disease | Key Feature | Typical Population |
|---|---|---|
| Idiopathic pulmonary fibrosis | Progressive fibrosis of unknown cause; "honeycomb lung" on imaging; poor prognosis | Typically presents in the sixth decade of life |
| Sarcoidosis | Non-caseating granulomas containing asteroid and Schaumann bodies; diagnosis of exclusion; elevated ACE level; bilateral hilar lymphadenopathy | Young Black women (classic exam demographic) |
| Hypersensitivity pneumonitis | Immune reaction to inhaled organic antigens (mold, bird proteins); improves away from exposure | Farmers, bird handlers |
| Pulmonary Langerhans cell histiocytosis | Langerhans cells with Birbeck granules on EM; cystic lesions in lung and rib; can predispose to pneumothorax | Smokers |
| Goodpasture syndrome | Anti-glomerular basement membrane antibodies attack lung and kidney basement membranes | Young men |
Sarcoidosis and hypersensitivity pneumonitis can look similar radiographically, but they differ in the fundamental trigger — sarcoidosis's granulomas form with no identifiable antigen (a diagnosis of exclusion), while HP's granulomas form in direct response to a specific inhaled organic antigen — which is why removing the exposure can reverse HP, whereas sarcoidosis requires immunosuppression instead.
Sarcoidosis Systemic Manifestations
- Pulmonary: dyspnea, dry cough, bilateral hilar adenopathy.
- Ophthalmologic: uveitis.
- Dermatologic: erythema nodosum.
- Metabolic: hypercalcemia from macrophage-mediated activation of vitamin D within granulomas.
- Cardiac: restrictive cardiomyopathy, conduction abnormalities.
- Characteristic anergy on tuberculin skin testing despite a hyperactive immune system overall (polyclonal hypergammaglobulinemia).
Occupational Lung Disease (Pneumoconiosis)
| Disease | Exposure | Distinctive Feature | Cancer Risk |
|---|---|---|---|
| Anthracosis | Carbon/soot (urban air, minor smoking exposure) | Usually asymptomatic; black macrophage pigment | None |
| Coal worker's pneumoconiosis | Coal dust | Can progress to progressive massive fibrosis | Not clearly increased |
| Silicosis | Silica (mining, sandblasting, quarrying) | Birefringent silica particles; upper lobe nodules | ↑ risk, also ↑ risk of TB reactivation |
| Asbestosis | Asbestos (shipbuilding, insulation, construction) | Ferruginous bodies (asbestos fibers coated with iron-protein); lower lobe fibrosis; pleural plaques | ↑↑ bronchogenic carcinoma (synergistic with smoking) and mesothelioma (independent of smoking) |
| Berylliosis | Beryllium (aerospace, electronics manufacturing) | Non-caseating granulomas — mimics sarcoidosis | ↑ lung cancer risk |
Mesothelioma is the more specific marker of asbestos exposure, but bronchogenic carcinoma is the more common cancer in asbestos-exposed patients overall — because asbestos and smoking act synergistically on lung cancer risk while mesothelioma risk from asbestos does not require smoking.
- Silica and coal dust both come from the ground and characteristically produce upper lobe disease, while asbestos — historically used overhead as insulation — characteristically produces lower lobe disease; a handy way to keep the lobar distributions straight.
- Silicosis classically shows "eggshell" calcification of the hilar lymph nodes on chest imaging.
- Caplan syndrome: rheumatoid arthritis occurring together with a pneumoconiosis (most classically coal worker's pneumoconiosis or silicosis), producing well-defined intrapulmonary nodules.
Mesothelioma
- Malignancy of the pleura strongly associated with asbestos exposure; can produce a hemorrhagic pleural effusion and diffuse pleural thickening.
- Histology classically shows psammoma bodies (concentric, laminated calcifications); on electron microscopy, tumor cells show long, slender microvilli.
- Immunohistochemistry positive for calretinin and cytokeratin 5/6 in nearly all cases — a useful way to distinguish mesothelioma from a metastatic adenocarcinoma involving the pleura, which is typically negative for these markers.
- Unlike bronchogenic carcinoma, tobacco smoking is not a risk factor for mesothelioma — asbestos exposure alone drives the risk.
🧬 Cystic Fibrosis
- Autosomal recessive; the most common lethal genetic disease in individuals of European descent.
- Caused by mutations in the CFTR gene (chromosome 7), a chloride channel; the most common mutation is a three-base-pair deletion causing loss of a phenylalanine residue (ΔF508), which impairs protein folding and trafficking.
Organ System Manifestations
| System | Manifestation |
|---|---|
| Pulmonary | Recurrent infections (early S. aureus, later P. aeruginosa), bronchiectasis — the leading cause of death in CF |
| Pancreatic | Exocrine insufficiency → malabsorption, steatorrhea, fat-soluble vitamin (A, D, E, K) deficiency; late endocrine insufficiency (CF-related diabetes) |
| GI | Meconium ileus in the newborn period |
| Reproductive | Congenital bilateral absence of the vas deferens → male infertility |
| Sweat glands | Elevated chloride concentration in sweat — the basis of the diagnostic sweat chloride test |
Every CF manifestation across organ systems traces back to the same defect — impaired chloride/water transport thickening secretions — so reasoning from CFTR's mechanism, rather than memorizing each organ's complication separately, predicts manifestations you haven't seen before (e.g., chronic sinusitis and nasal polyps).
The mechanism and presentation of bronchiectasis, CF's leading cause of death, are covered with Obstructive Lung Disease → Bronchiectasis.
Treatment Principles
- Airway clearance techniques + mucolytics (N-acetylcysteine, dornase alfa) to reduce mucus viscosity.
- Pancreatic enzyme replacement and fat-soluble vitamin supplementation.
- CFTR modulator drugs (e.g., ivacaftor-class agents) directly target specific mutation classes — a major advance in disease-modifying therapy.
- Aggressive antibiotic therapy for pulmonary exacerbations.
🫁 Embryology & Development
Why surfactant production ramping up in the saccular stage is what determines viability at birth is explained mechanistically with Surfactant & Neonatal Respiratory Distress → Laplace's Law and the Need for Surfactant.
Timeline of Lower Airway Formation
- Epithelial lining of the larynx, trachea, bronchi, and alveoli — endodermal origin.
- Cartilage, smooth muscle, and connective tissue of the airway wall — splanchnic mesoderm origin.
- Five embryologic stages of lung maturation, each with a distinct structural hallmark:
- Embryonic (wk 4–7): lung buds branch into main/lobar/segmental bronchi.
- Pseudoglandular (wk 7–17): airway branching complete down to terminal bronchioles; gland-like appearance on histology; lung is non-viable if born in this stage.
- Canalicular (wk 17–26): respiratory bronchioles form; vascularization increases; type II pneumocytes appear near the end of this stage.
- Saccular (wk 26–birth): terminal saccules form, thinning of interstitium; surfactant production ramps up.
- Alveolar (wk 36–~8 yrs postnatal): true alveoli proliferate; most alveolar development is postnatal.
Extremely premature infants (born in the canalicular stage or earlier) are non-viable primarily because of insufficient gas-exchange surface and surfactant, not just prematurity itself.
Tracheoesophageal Fistula (TEF) / Esophageal Atresia
- Caused by abnormal partitioning of the tracheoesophageal septum → incomplete separation of trachea from esophagus.
- Most common configuration: proximal esophagus ends blindly (atresia) while the distal esophageal segment communicates with the trachea.
- This is the single most common congenital anomaly of the lower respiratory tract.
- Clinical clues:
- Copious oral secretions / drooling, choking with first feeds.
- Inability to pass an orogastric tube — tube coils in the blind pouch.
- Air visible in the stomach on imaging (because the distal fistula lets air into the GI tract).
- Recurrent aspiration pneumonia.
- Polyhydramnios results because the fetus cannot swallow amniotic fluid effectively.
- Associated with the VACTERL association (Vertebral, Anal, Cardiac, TE fistula, Renal, Limb anomalies) — always screen for the others if one is found.
Diaphragm Development
- Four embryologic contributors fuse to form the diaphragm:
- Septum transversum — becomes the central tendon.
- Pleuroperitoneal membranes — close the pericardioperitoneal canals.
- Dorsal mesentery of the esophagus — forms the crura.
- Body wall musculature — contributes the peripheral rim.
- Innervated by the phrenic nerve (C3–C5) — reflects the diaphragm's cervical origin and explains referred shoulder-tip pain with diaphragmatic irritation.
Congenital Diaphragmatic Hernia (CDH)
- Failure of pleuroperitoneal membrane closure, classically posterolateral and left-sided (foramen of Bochdalek) in roughly 90% of cases, because the right pleuroperitoneal opening closes earlier in development.
- Abdominal viscera herniate into the thorax → compress the ipsilateral (and often contralateral) developing lung → pulmonary hypoplasia.
- Presents at birth with respiratory distress, a scaphoid (flattened) abdomen, and bowel sounds heard in the chest.
- Also associated with polyhydramnios.
Other Developmental Anomalies
- Pulmonary sequestration: non-functioning lung tissue with no connection to the bronchial tree, supplied by a systemic (not pulmonary) artery.
- Bronchogenic cyst: abnormal budding of the foregut; presents as a mediastinal or hilar mass, often incidental.
- Congenital pulmonary airway malformation (CPAM): cystic, non-functional lung tissue that communicates with the airway; risk of infection or, rarely, malignant transformation.
In CDH, it's the resulting pulmonary hypoplasia — not the herniated abdominal contents themselves — that drives neonatal mortality, because normal lung development needs adequate thoracic space during the canalicular/saccular windows; this is why prognosis tracks fetal lung volume on prenatal imaging more closely than hernia size does.
🌳 Gross & Histologic Anatomy
Conducting Zone vs Respiratory Zone
| Conducting zone | Respiratory zone | |
|---|---|---|
| Structures | Nose → pharynx → larynx → trachea → bronchi → bronchioles → terminal bronchioles | Respiratory bronchioles → alveolar ducts → alveoli |
| Function | Warms, humidifies, filters air; no gas exchange ("anatomic dead space") | Site of gas exchange |
| Epithelium | Pseudostratified ciliated columnar (bronchi) → transitions to cuboidal near terminal bronchioles | Cuboidal in respiratory bronchioles → simple squamous at the alveoli |
| Airway resistance | Highest in the medium-sized bronchi (not the smallest airways, which are numerous and arranged in parallel — least total resistance) | — |
Airway resistance peaks in the medium bronchi rather than the tiny terminal airways, because although each small airway is narrow, their sheer numbers arranged in parallel make the total cross-sectional area — and thus total resistance — smallest there; this is also why early small-airway disease can stay clinically silent before spirometry ever picks it up.
- Cartilage and mucus-producing goblet cells extend as far as the end of the bronchi; smooth muscle extends slightly further, to the end of the terminal bronchioles (and is sparse beyond that point).
- Cilia are present through the respiratory bronchioles and disappear at the alveolar duct — the mucociliary escalator physically cannot clear debris that reaches the alveoli, which is why alveolar macrophages take over that job distally.
Alveolar Cell Types
Type I pneumocytes
- Squamous, make up ~97% of the alveolar surface area.
- Extremely thin to minimize diffusion distance for gas exchange — cannot divide.
Type II pneumocytes
- Cuboidal, clustered; store surfactant in lamellar bodies.
- Act as the progenitor cell for both type I and type II pneumocytes — proliferate to repopulate the epithelium after lung injury.
Type I and type II pneumocytes divide the alveolar job between them — type I maximizes surface area for gas exchange but can't divide, so type II (which can) doubles as both the surfactant factory and the reserve stem cell that repopulates type I after injury.
- Club (Clara) cells: nonciliated secretory cells of the bronchioles; detoxify inhaled substances via cytochrome P-450, secrete a surfactant-like component, and serve as a bronchiolar stem cell population.
- Alveolar macrophages ("dust cells"): phagocytose inhaled particulates and pathogens; hemosiderin-laden forms ("heart failure cells") accumulate after alveolar hemorrhage or pulmonary edema.
- Pores of Kohn: small openings connecting adjacent alveoli, allowing collateral air flow — but also a route by which infection (e.g., pneumonia) can spread between alveoli.
Gross Lobar Anatomy & the Right/Left Asymmetry
- Right lung: 3 lobes (upper, middle, lower). Left lung: 2 lobes (upper, lower) plus the lingula, a tongue-like projection that is the developmental counterpart of the right middle lobe — the left lung is smaller to make room for the heart.
- At each hilum, the relationship of the pulmonary artery to the bronchus differs by side: the artery sits anterior to the bronchus on the right and superior to it on the left — a fact worth memorizing as a fixed right-anterior/left-superior pairing.
- The right main bronchus is wider, more vertical, and shorter than the left, so aspirated material (and inhaled foreign bodies generally) preferentially enters the right lung — most often the right lower lobe in an upright or supine patient (see Lung Defenses for the aspiration-position specifics).
Diaphragm: Structures at Each Level
| Vertebral level | Structure(s) passing through |
|---|---|
| T8 | Inferior vena cava, right phrenic nerve |
| T10 | Esophagus, vagus nerve (both trunks) |
| T12 | Aorta, thoracic duct, azygos vein |
- A simple way to keep the order straight: the number of structures at each level roughly tracks the vertebral level itself — 2 at T8 (IVC, phrenic), a couple at T10 (esophagus, vagus — 2 trunks), and 3 at T12 (aorta, thoracic duct, azygos).
- The diaphragm is innervated by the phrenic nerve (C3–C5, per the embryology above); irritation refers pain to the shoulder (C5) and trapezius ridge (C3–C4).
- Phrenic nerve injury (e.g., from a mediastinal tumor) causes elevation of the ipsilateral hemidiaphragm on imaging.
Thoracentesis
- Needle enters just above the rib at the chosen intercostal space, to avoid the neurovascular bundle that runs just beneath each rib.
- Avoid inserting below the 9th rib to reduce the risk of injuring abdominal organs (liver on the right, spleen on the left).
💧 Surfactant & Neonatal Respiratory Distress
Laplace's Law and the Need for Surfactant
- Small alveoli generate higher collapsing pressure than large ones for the same surface tension — without a stabilizing mechanism, small alveoli would empty into large ones.
- Surfactant lowers surface tension proportionally more in small alveoli (its molecules pack more densely as the alveolus shrinks) → equalizes pressures across alveoli of different sizes → prevents atelectasis.
Laplace's law is why alveoli of different sizes don't simply empty into each other despite being interconnected via the pores of Kohn — surfactant's size-dependent effect on surface tension is what keeps the system stable, and losing that stabilization is what drives diffuse micro-atelectasis in NRDS rather than a few large alveoli forming.
Surfactant Biology
- Produced by type II pneumocytes — cuboidal, surfactant-storing cells with characteristic lamellar bodies.
- Type II pneumocytes are also the reserve/progenitor cell that repopulates type I pneumocytes (the thin, gas-exchanging cell type) after lung injury.
- Main phospholipid component: dipalmitoylphosphatidylcholine.
- Fetal lung maturity can be estimated from amniotic fluid: a lecithin:sphingomyelin ratio ≥ 2 suggests adequate surfactant production (a ratio < 1.5 predicts a substantial NRDS risk); the foam stability index and surfactant-albumin ratio are additional screening tests used for the same purpose.
Neonatal Respiratory Distress Syndrome (NRDS)
- Risk increases sharply with decreasing gestational age; also increased by maternal diabetes (fetal hyperinsulinemia delays surfactant maturation) and cesarean delivery without labor.
- Antenatal maternal corticosteroids accelerate fetal surfactant production when preterm delivery is anticipated.
- Postnatal management: exogenous surfactant administration, supplemental oxygen, and positive pressure support.
- Complications of prematurity/NRDS management: retinopathy of prematurity (high FiO2), bronchopulmonary dysplasia (barotrauma/oxygen toxicity), intraventricular hemorrhage.
- Widespread alveolar collapse (atelectasis) is itself a direct downstream complication of surfactant deficiency in NRDS.
ARDS and NRDS both show hyaline membranes histologically, but the underlying mechanism differs completely — neutrophil-mediated capillary injury in ARDS vs. surfactant deficiency in NRDS. Don't let the shared finding imply a shared cause.
🤧 Upper Respiratory Tract Infections
- Viral rhinitis (common cold): overwhelmingly rhinovirus and coronavirus, also caused by adenovirus and parainfluenza virus; self-limited. In adults, parainfluenza virus itself tends to produce an illness resembling the ordinary common cold, spread by respiratory droplets.
- Bacterial rhinitis: usually a secondary superinfection following an initial viral rhinitis; commonly caused by Streptococcus, Staphylococcus, and H. influenzae.
- Acute sinusitis: usually a viral prodrome; bacterial superinfection (S. pneumoniae, H. influenzae, Moraxella) suspected if symptoms persist beyond ~10 days or worsen after initial improvement ("double worsening").
- Otitis externa: infection of the external auditory canal, classically linked to moisture exposure ("swimmer's ear"); the leading cause is Pseudomonas aeruginosa.
- Otitis media: same bacterial culprits as sinusitis; most common in young children due to a shorter, more horizontal eustachian tube.
- Allergic rhinitis: type I (IgE-mediated) hypersensitivity; nasal eosinophilia on smear.
- Laryngitis: hoarseness from vocal cord inflammation — infectious (often viral) or from vocal overuse.
Nose & Paranasal Sinuses
- Rhinosinusitis: obstruction of normal sinus drainage → inflammation and pain over the affected sinus. The maxillary sinus is most often involved, in part because its drainage opening sits high on its medial wall, so it must drain against gravity. Usually viral at onset (e.g., rhinovirus), with occasional bacterial superinfection.
- Epistaxis: most nosebleeds originate anteriorly, from a rich vascular anastomosis on the septum (the Kiesselbach plexus). Severe, harder-to-control bleeds instead arise more posteriorly, from a branch of the maxillary artery. Common triggers include trauma, dryness/foreign body, and allergic rhinitis.
- Choanal atresia: congenital blockage of the posterior nasal opening; suspect it when a newborn cannot have a catheter passed through the nose into the pharynx. Bilateral cases are a neonatal emergency (infants are obligate nose-breathers) and often occur as part of a broader malformation pattern that also includes eye, cardiac, growth, genitourinary, and ear anomalies.
Croup vs Epiglottitis
| Croup (Laryngotracheobronchitis) | Epiglottitis | |
|---|---|---|
| Organism | Parainfluenza virus | Haemophilus influenzae type b (rare now due to vaccination) |
| Onset | Gradual — preceding upper respiratory symptoms | Abrupt, rapidly progressive |
| Hallmark sign | Barking (seal-like) cough, inspiratory stridor; "steeple sign" on X-ray | Drooling, tripod/sniffing position, muffled ("hot potato") voice; "thumbprint sign" on lateral X-ray |
| Severity | Usually self-limited | True airway emergency — risk of sudden complete obstruction |
| Approach | Supportive ± corticosteroids/nebulized epinephrine | Secure the airway urgently (often in OR); avoid agitating the child or examining the throat directly |
Widespread H. influenzae type b vaccination has dramatically reduced the incidence of epiglottitis since its introduction; in unvaccinated children, the same organism remains an important cause of bacterial meningitis as well.
⚠️ Drug-Induced Pulmonary Disease
The COX-1-to-leukotriene shunt that drives NSAID/aspirin-induced bronchospasm is explained mechanistically with Asthma & COPD Pharmacology → Aspirin-Exacerbated Respiratory Disease Mechanism.
| Effect | Causative Drugs |
|---|---|
| Pulmonary fibrosis | Bleomycin, busulfan, amiodarone, methotrexate, nitrofurantoin (chronic use) |
| Chronic dry cough | ACE inhibitors (bradykinin accumulation) — resolves with switch to an ARB, which does not share this effect |
| Non-cardiogenic pulmonary edema | Opioid overdose, salicylate toxicity |
| Bronchospasm | Non-selective β-blockers (unmask bronchoconstriction in susceptible patients), aspirin/NSAIDs in AERD |
Grouping these by mechanism rather than by drug name predicts new culprits — agents that cause chronic tissue injury/fibrosis over time (bleomycin, amiodarone, nitrofurantoin), agents that block bradykinin breakdown (ACE inhibitors → cough), and agents that raise airway reactivity in a susceptible patient (β-blockers, NSAIDs in AERD → bronchospasm) are three distinct pathways, not one.
ACE inhibitor cough is a class effect tied to bradykinin, not angiotensin II — that's precisely why switching to an angiotensin receptor blocker (which spares bradykinin metabolism) resolves it.
💊 Allergy, Cough & Cold Pharmacology
| Class | Agents | Notes |
|---|---|---|
| First-generation antihistamine | Diphenhydramine, chlorpheniramine | Crosses blood-brain barrier → sedation, anticholinergic effects |
| Second-generation antihistamine | Loratadine, cetirizine, fexofenadine | Less lipophilic → minimal sedation |
| Intranasal corticosteroid | Fluticasone, mometasone | First-line maintenance therapy for allergic rhinitis |
| Expectorant | Guaifenesin | Thins mucus; does not suppress cough reflex |
| Mucolytic | N-acetylcysteine | Breaks disulfide bonds in mucus glycoproteins; also the antidote for acetaminophen overdose and used off-label for prophylaxis against radiocontrast-induced nephropathy |
| Antitussive (opioid) | Dextromethorphan, codeine | Suppresses the medullary cough center |
| Decongestant | Pseudoephedrine, phenylephrine | α-agonist → vasoconstriction of nasal mucosa; can raise blood pressure |
Antihistamine generations differ mainly in lipophilicity/blood-brain-barrier penetration rather than receptor mechanism — first-generation agents cross into the CNS and cause sedation, second-generation agents are engineered to stay largely peripheral — which is the basis for preferring second-generation agents for daytime allergy control.